Navigating GMO Landscape following the EU Clinical Trial Regulation 536/2014 implementation
In a rapidly evolving regulatory environment, understanding the EU GMO landscape is crucial for biotech and pharma companies navigating clinical trials. Ergomed’s recent webinar, now available on demand, provides expert guidance on the latest GMO requirements within the centralized CTA submission framework under EU Clinical Trial Regulation 536/2014. Key Takeaways Include: Understanding GMOs … Continued